Cyclic peptide based angiogenic inhibitors. [ 2012 - 2014 ]

Research Grant

Researchers: Prof David Craik (Principal investigator) ,  Prof Norelle Daly

Brief description This project aims to develop a novel class of drugs with the potential to overcome the stability problems previously associated with protein-based drugs. We will develop novel molecules for the treatment of cancer and cardiovascular disease. This project has the potential to lead to major economic and social benefits to Australia via royalty returns from drug sales and reduced costs for health care for patients with these diseases.

Funding Amount $AUD 376,258.57

Funding Scheme Project Grants

Notes Standard Project Grant